Sparrow Pharmaceuticals Expands Clinical Trial to Treat Polymyalgia Rheumatica
By Daniella Parra Sparrow Pharmaceuticals expanded its Phase 2 clinical trial for SPI-62 in combination with prednisolone to treat polymyalgia rheumatica (PMR), the company said. The trial is exploring the potential benefits of SPI-62 in reducing the side effects of...